Michona Robinson
Hematology & Oncology · Dalton, GANPI 1790367480
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $969 of the $1,132 with a category attached, or 85.6%. It is spread thinly across 23 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $449 and has fallen 72.6% since, to $123 in 2025. That places this record below the midpoint for hematology & oncology clinicians in GA, where the typical reported total is $4,479.
Across 60 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$161
- Seagen Inc.$152
- AbbVie$139
- Pfizer$116
- E.r. Squibb & Sons, L.L.C.$60
- Bristol Myers Squibb$53
- plus $451 from 17 others
What the payments were for
- Food & beverage$96986%
- Education$16314%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $161 |
| Seagen Inc. | 5 | $152 |
| AbbVie | 8 | $139 |
| Pfizer | 8 | $116 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Bristol Myers Squibb | 3 | $53 |
| Amgen | 3 | $52 |
| GSK | 2 | $49 |
| Incyte Corporation | 2 | $48 |
| Merck | 2 | $39 |
| Eisai Inc. | 2 | $31 |
| Gilead | 1 | $26 |
| Beigene USA, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| TG Therapeutics, Inc. | 1 | $20 |
| Puma Biotechnology, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Deciphera Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Novartis | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
How this compares
$1,132 in reported general payments places this provider in the 25th percentile of 370 hematology & oncology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 15 | $42 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Dalton
- Priya RudolphAthens$745K
- Aron KefelaHiram$591K
- Chandar BhimaniConyers$483K
- Ticiana LealAtlanta$450K
- Steven McCuneMarietta$450K
- Jorge LeguizamoLawrenceville$409K
- Trevor FeinsteinFayetteville$341K
- Jigarkumar ParikhAugusta$267K
- Ajay NookaAtlanta$222K
- Abdullah KutlarAugusta$196K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.